Target intelligence / Profile preview

Human red blood cell membrane (RBC membrane)

Target
RBC membrane
Molecular classification
Other (composite biological membrane), Ion channel, Enzyme, Transporter, Structural protein, Receptor
01

Overview

The human red blood cell membrane is a composite biological membrane that envelops erythrocytes, consisting of a lipid bilayer supporting numerous embedded and peripheral proteins. It comprises three structural layers: the outer glycocalyx (rich in carbohydrates), the lipid bilayer (containing nearly equal masses of cholesterol and phospholipids with asymmetric distribution across leaflets), and the cytoskeletal protein network (predominantly spectrin, actin, ankyrin, protein 4.1, band 3, among others)[2][1][5][4]. These features confer unique mechanical properties, such as exceptional deformability and durability, critical for red cell survival in circulation[1][2][5]. The membrane proteins serve diverse functions—including ion transport, structural support, and cell-cell recognition—while its loss of integrity or alteration underlies various hereditary hemolytic anemias and can mediate susceptibility to blood-borne pathogens or immunological attack[3][5][4]. While not a therapeutic target as a whole, it contains many proteins that are disease-associated or have pharmacological relevance. In summary: \"Human red blood cell membrane\" is not a canonical therapeutic target or molecule, but a highly specialized composite structure essential to red cell function, containing many distinct molecular targets and disease roles, and must be subdivided for meaningful pharmacological analysis[2][1][5][3][4].

Other names
Red cell membraneerythrocyte membraneRBC membraneRBCcmerythrocyte plasma membrane
02

Mechanism of action

Not applicable to the membrane as a whole; for membrane proteins, mechanisms include inhibition of ion transport, alteration of cytoskeletal interactions, blocking of pathogen entry, etc.

03

Biological functions

Oxygen and carbon dioxide transport (by maintaining red blood cell shape and deformability)Membrane deformability and structural integrityRegulation of ion exchange and volumeCell–cell interactionImmune evasionSignal transduction (via surface proteins)
04

Disease associations

Hemolytic anemia (hereditary spherocytosis, elliptocytosis, stomatocytosis, Southeast Asian ovalocytosis, other red cell membrane disorders)Cardiovascular disease (via impaired oxygen delivery or hemolysis)Infection (specific blood group antigens can serve as entry receptors for Plasmodium, etc.)Other (many rare hereditary diseases)
05

Safety considerations

Targeting the membrane broadly risks hemolysis, anemia, or immune cytotoxicityAutoimmune hemolytic anemia risk from immune responses to membrane antigensOff-target effects due to ubiquitous basic membrane structure in all cells
06

Interacting drugs

None specific to the membrane as a whole; individual drugs target specific proteins (e.g., Band 3 inhibitors, ion transporter inhibitors, anti-malarials that interact with red cell entry point).
07

Biomarkers

Band 3 (anion exchange protein)Glycophorins (A, B, C—blood group antigens)CD47 ("don’t eat me" signal)Spectrin, ankyrin, actin, protein 4.1, protein 4.2 levels (for hereditary membrane disorders)

Beyond the preview

Go deeper on Human red blood cell membrane (RBC membrane).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human red blood cell membrane (RBC membrane).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call